ArticleClinical immunology (Orlando, Fla.)2021

Commentary on "Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy" by D.C. Mastellos et al.

Isabel Kinney Ferreira de Miranda Santos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.